Avanti Acquisition (AVAN) 10-Q16 May 222022 Q1 Quarterly reportFinancial data

Company Profile

Cover Page

Cover Page - shares	3 Months Ended
Cover Page - shares	Mar. 31, 2022	May 16, 2022
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2022
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q1
Current Fiscal Year End Date	--12-31
Document Transition Report	false
Entity File Number	001-39586
Entity Registrant Name	AVANTI ACQUISITION CORP.
Entity Tax Identification Number	98-1550179
Entity Incorporation, State or Country Code	E9
Entity Address, Address Line One	PO Box 1093
Entity Address, Address Line Two	Boundary Hall
Entity Address, Address Line Three	Cricket Square
Entity Address, City or Town	Grand Cayman
Entity Address, Postal Zip Code	KY1-1102
Entity Address, Country	KY
City Area Code	345
Local Phone Number	814-5831
Entity Central Index Key	0001819608
Entity Current Reporting Status	No
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	true
Common Class A [Member]
Document Information [Line Items]
Title of 12(b) Security	Class A Ordinary Shares included as part of the units
Trading Symbol	AVAN
Security Exchange Name	NYSE
Entity Common Stock, Shares Outstanding		60,000,000
Common Class B [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		15,000,000
Capital Units [Member]
Document Information [Line Items]
Title of 12(b) Security	Units, each consisting of one Class A Ordinary Share, $0.0001 par value, and one-half of one redeemable warrant
Trading Symbol	AVAN.U
Security Exchange Name	NYSE
Warrant [Member]
Document Information [Line Items]
Title of 12(b) Security	Redeemable warrants included as part of the units, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
Trading Symbol	AVAN WS
Security Exchange Name	NYSE

CONDENSED BALANCE SHEETS

CONDENSED BALANCE SHEETS - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Current assets
Cash	$ 194,134	$ 67,132
Prepaid expenses	339,351	375,624
Total Current Assets	533,485	442,756
Investments held in Trust Account	600,096,322	600,046,438
TOTAL ASSETS	600,629,807	600,489,194
Current liabilities
Accounts payable and accrued expenses	209,861	103,247
Promissory note – related party	843,236	468,236
Total Current Liabilities	1,053,097	571,483
FPA liabilities	29,991	1,014,997
Warrant liabilities	11,440,000	26,048,000
Deferred underwriting fee payable	21,000,000	21,000,000
TOTAL LIABILITIES	33,523,088	48,634,480
Class A ordinary shares subject to possible redemption, 60,000,000 shares at $10.00 per share redemption value as of March 31, 2022 and December 31, 2021	600,000,000	600,000,000
Shareholders' Deficit
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued or outstanding as of March 31, 2022 and December 31, 2021
Additional paid-in capital
Accumulated deficit	(32,894,781)	(48,146,786)
Total Shareholders' Deficit	(32,893,281)	(48,145,286)
TOTAL LIABILITIES, ORDINARY SHARES SUBJECT TO REDEMPTION AND SHAREHOLDERS' DEFICIT	600,629,807	600,489,194
Class A Ordinary Share [Member]
Shareholders' Deficit
Ordinary shares
Class B Ordinary Share [Member]
Shareholders' Deficit
Ordinary shares	$ 1,500	$ 1,500

CONDENSED BALANCE SHEETS (Paren

CONDENSED BALANCE SHEETS (Parenthetical) - $ / shares	Mar. 31, 2022	Dec. 31, 2021
Preferred Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Preferred Stock, Shares Authorized	5,000,000	5,000,000
Preferred Stock, Shares Issued	0	0
Preferred Stock, Shares Outstanding	0	0
Class A Ordinary Share [Member]
Common Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Common Stock, Shares Authorized	500,000,000	500,000,000
Common Stock, Shares, Issued	0	0
Common Stock, Shares, Outstanding	0	0
Shares subject to possible redemption	60,000,000	60,000,000
Redemption price per share	$ 10	$ 10
Class B Ordinary Share [Member]
Common Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Common Stock, Shares Authorized	50,000,000	50,000,000
Common Stock, Shares, Issued	15,000,000	15,000,000
Common Stock, Shares, Outstanding	15,000,000	15,000,000

CONDENSED STATEMENTS OF OPERATI

CONDENSED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended
CONDENSED STATEMENTS OF OPERATIONS - USD ($)	Mar. 31, 2022	Mar. 31, 2021
Operating costs	$ 390,885	$ 400,941
Loss from operations	(390,885)	(400,941)
Other income:
Interest earned on investments held in Trust Account	49,884	9,018
Change in fair value of FPA liabilities	985,006	5,054,119
Change in fair value of warrant liabilities	14,608,000	20,240,000
Total other income	15,642,890	25,303,137
Net income	15,252,005	24,902,196
Class A Ordinary Share [Member]
Other income:
Net income	$ 12,201,604	$ 19,921,757
Weighted average shares outstanding	60,000,000	60,000,000
Basic and diluted net loss per share	$ 0.20	$ 0.33
Class B Ordinary Share [Member]
Other income:
Net income	$ 3,050,401	$ 4,980,439
Weighted average shares outstanding	15,000,000	15,000,000
Basic and diluted net loss per share	$ 0.20	$ 0.33

CONDENSED STATEMENTS OF CHANGES

CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIT - USD ($)	Total	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Class B Ordinary Share [Member]	Class B Ordinary Share [Member]Common Stock [Member]
Beginning balance, shares at Dec. 31, 2020					15,000,000
Beginning Balance at Dec. 31, 2020	$ (94,704,334)	$ 0	$ (94,705,834)		$ 1,500
Net income	24,902,196		24,902,196	$ 4,980,439
Ending balance, shares at Mar. 31, 2021					15,000,000
Ending balance at Mar. 31, 2021	(69,802,138)	0	(69,803,638)		$ 1,500
Beginning balance, shares at Dec. 31, 2021					15,000,000
Beginning Balance at Dec. 31, 2021	(48,145,286)	0	(48,146,786)		$ 1,500
Net income	15,252,005		15,252,005	$ 3,050,401
Ending balance, shares at Mar. 31, 2022					15,000,000
Ending balance at Mar. 31, 2022	$ (32,893,281)	$ 0	$ (32,894,781)		$ 1,500

CONDENSED STATEMENTS OF CASH FL

CONDENSED STATEMENTS OF CASH FLOWS - USD ($)	3 Months Ended
CONDENSED STATEMENTS OF CASH FLOWS - USD ($)	Mar. 31, 2022	Mar. 31, 2021
Cash Flows from Operating Activities:
Net income	$ 15,252,005	$ 24,902,196
Adjustments to reconcile net income to net cash used in operating activities:
Change in fair value of warrant liabilities	(14,608,000)	(20,240,000)
Change in fair value of FPA liability	(985,006)	(5,054,119)
Prepaid expenses	36,273	(558,984)
Interest earned on investments held in Trust Account	(49,884)	(9,018)
Accounts payable and accrued expenses	106,614	198,018
Net cash used in operating activities	(247,998)	(761,907)
Cash Flows from Financing Activities:
Proceeds from promissory note—related party	375,000	0
Net cash provided by financing activities	375,000	0
Net Change in Cash	127,002	(761,907)
Cash – Beginning of period	67,132	1,194,821
Cash – End of period	$ 194,134	$ 432,914

Description of Organization and

Description of Organization and Business Operations	3 Months Ended
Description of Organization and Business Operations	Mar. 31, 2022
Accounting Policies [Abstract]
Description of Organization and Business Operations	NOTE 1 — DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Avanti Acquisition Corp. (the “Company”) was incorporated in the Cayman Islands on July 24, 2020. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities (the “Business Combination”). The Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. As of March 31, 2022, the Company had not commenced any operations. All activity through March 31, 2022 relates to the Company’s formation, the initial public offering (the “Initial Public Offering”), which is described below, and identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating The registration statement for the Company’s Initial Public Offering was declared effective on October 1, 2020. On October 6, 2020, the Company consummated the Initial Public Offering of 60,000,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units sold, the “Public Shares”), generating gross proceeds of $600,000,000 which is described in Note 3. Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 14,000,000 warrants (the “Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant in a private placement to Avanti Acquisition SCSp (the “Sponsor”), generating gross proceeds of $14,000,000, which is described in Note 4. Transaction costs amounted to $33,588,903, consisting of $12,000,000 of underwriting fees, $21,000,000 of deferred underwriting fees and $588,903 of other offering costs. Following the closing of the Initial Public Offering on October 6, 2020, an amount of $600,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”) located in the United States and is invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. So long as the Company’s securities are then listed on the NYSE, the Company’s initial Business Combination must be with one or more target businesses that together have a fair market value of at least 80% of the net assets held in the Trust Account (excluding the amount of deferred underwriting discounts and taxes payable on the income earned) at the time of the signing of the agreement to enter into a Business Combination. The Company will only complete a Business Combination if the post business combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company will provide the holders of its issued and outstanding Public Shares (the “public shareholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company. The public shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially $10.00 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay income taxes). The per-share The Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, only if a majority of the ordinary shares, represented in person or by proxy and entitled to vote thereon and who vote at a shareholder meeting, are voted in favor of the Business Combination. If a shareholder vote is not required by law and the Company does not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association, conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (the “SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transactions is required by law, or the Company decides to obtain shareholder approval for business or reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each public shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction or vote at all. If the Company seeks shareholder approval in connection with a Business Combination, the Sponsor, executive officers and directors (the “initial shareholders”) have agreed to vote their Founder Shares (as defined in Note 4) and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination. Notwithstanding the foregoing, if the Company seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Amended and Restated Memorandum and Articles of Association provides that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public Shares, without the prior consent of the Company. The initial shareholders have agreed to waive their redemption rights with respect to any Founder Shares and Public Shares held by them in connection with (i) the completion of the Company’s initial Business Combination and (ii) a shareholder vote to approve an amendment to the Company’s Amended and Restated Memorandum and Articles of Association (A) that would modify the substance or timing of the Company’s obligation to provide holders of the Public Shares the right to have their shares redeemed in connection with the Company’s initial Business Combination or to redeem 100% of the Public Shares if the Company does not complete its initial Business Combination by October 6, 2022 or (B) with respect to any other provision relating to the rights of holders of the Public Shares. The Company will have until October 6, 2022 to complete a Business Combination (the “Combination Period”). If the Company has not completed complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible, but not more than ten business days thereafter, redeem the Public Shares, at aper-shareprice, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to pay income taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then issued and outstanding Public Shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and the Company’s board of directors, dissolve and liquidate, subject in the case of clauses (ii) and (iii) to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period. The initial shareholders have agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the initial shareholders acquire Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 5) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per-share In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amounts in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account if less than $10.00 per Public Share due to reductions in the value of the trust assets. This liability will not apply with respect to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account nor to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except for the Company’s independent auditors), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Going Concern and Liquidity As of March 31, 2022, the Company had $194,134 in its operating bank accounts and working capital deficit of $519,612. Prior to the completion of the Initial Public Offering, the Company’s liquidity needs had been satisfied through a contribution of $25,000 from Sponsor to cover for certain offering costs in exchange for the issuance of the Founder Shares, the loan of up to $300,000 from the Sponsor pursuant to the Promissory Note (see Note 4), advances from the Sponsor, and the proceeds from the consummation of the Private Placement not held in the Trust Account. The Promissory Note and the Advances from Related Party were repaid on October 16, 2020. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans up to $1,500,000 (see Note 4). As of March 31, 2022, $843,236 were outstanding under the 2022 Promissory Note (as defined in Note 4). The Company will need to raise additional capital through loans or additional investments from its Sponsor, shareholders, officers, directors, or third parties. The Company’s officers, directors and Sponsor may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. These conditions raise substantial doubt about the Company’s ability to continue as a going concern for a reasonable period of time, which is considered to be one year from the issuance date of the condensed financial statements. These condensed financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern. In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”)2014-15,

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
Summary of Significant Accounting Policies	Mar. 31, 2022
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	NOTE 2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q S-X The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K, Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging Use of Estimates The preparation of condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these condensed financial statements is the determination of the fair value of the warrant liability and FPA liability. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of March 31, 2022 and December 31, 2021. Warrant and FPA Liabilities The Company accounts for the Warrants and FPA in accordance with the guidance contained in FASB Accounting Standards Codification (“ASC”) 815-40, Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in FASB ASC Topic 480 “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at March 31, 2022 and December 31, 2021, Class A ordinary shares subject to possible redemption are presented as temporary deficit, outside of the shareholders’ equity section of the Company’s condensed balance sheets. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. At March 31, 2022 and December 31, 2021, the Class A ordinary shares reflected in the condensed balance sheets are reconciled in the following table: Gross proceeds $ 600,000,000 Less: Proceeds allocated to Public Warrants (37,500,000 ) Class A ordinary shares issuance costs (31,473,651 ) Plus: Accretion of carrying value to redemption value 68,973,651 Class A ordinary shares subject to possible redemption $ 600,000,000 Offering Costs Associated with the Initial Public Offering Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. The Company classifies deferred underwriting commissions as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities. Income Taxes ASC Topic 740, “Income Taxes,” prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of March 31, 2022 and December 31, 2021, there were unrecognized tax benefits and amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the periods presented. Net Income per Ordinary Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income per ordinary share is computed by dividing net income by the weighted average number of ordinary shares outstanding for the period. The Company applies the two-class The calculation of diluted income per ordinary share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence of future events. The warrants are exercisable to purchase 44,000,000 Class A ordinary shares in the aggregate. For the three months ended March 31, 2022 and 2021, the Company did not have any other dilutive securities or other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted net income per ordinary shares is the same as basic net income per ordinary share for the periods presented. The following table reflects the calculation of basic and diluted net income per ordinary share (in dollars, except per share amounts): For the Three Months Ended For the Three Months Ended Class A Class B Class A Class B Basic and diluted net income per ordinary share Numerator: Allocation of net income, as adjusted $ 12,201,604 $ 3,050,401 $ 19,921,757 $ 4.980.43 Denominator: Basic and diluted weighted average shares outstanding 60,000,000 15,000,000 60,000,000 15,000,000 Basic and diluted net income per ordinary share $ 0.20 $ 0.20 $ 0.33 $ 0.33 Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the Company’s condensed balance sheets, primarily due to their short-term nature, except for the Warrants and FPA liability (see Note 8). Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: • Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. Recent Accounting Standards In August 2020, the FASB issued ASU 2020-06, (Subtopic 470-20) and (Subtopic 815-40) (“ASU 2020-06”) to ASU 2020-06 eliminates ASU 2020-06 amends the if-converted method ASU 2020-06 is ASU 2020-06 would Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed financial statements.

Initial Public Offering

Initial Public Offering	3 Months Ended
Initial Public Offering	Mar. 31, 2022
Initial Public Offering [Abstract]
Initial Public Offering	NOTE 3 — INITIAL PUBLIC OFFERING On October 6, 2020, pursuant to the Initial Public Offering, the Company sold 60,000,000 Units, at a purchase price of $10.00 per Unit. Each Unit consists of one Class A ordinary share and one-half

Related Party Transactions

Related Party Transactions	3 Months Ended
Related Party Transactions	Mar. 31, 2022
Related Party Transactions [Abstract]
Related Party Transactions	NOTE 4 — RELATED PARTY TRANSACTIONS Founder Shares On July 25, 2020, the Sponsor paid $25,000 to cover certain offering costs of the Company in consideration of 14,375,000 Class B ordinary shares, par value $0.0001. On October 1, 2020 the Company effected a share capitalization resulting in 17,250,000 Class B ordinary shares issued and outstanding (the “Founder Shares”). All share and per-share as-converted The initial shareholders have agreed, subject to limited exceptions, not to transfer, assign or sell their Founder Shares until the earlier of (i) one year after the completion of the Company’s Business Combination and (ii) subsequent to a Business Combination, (x) if the closing price of the Company’s Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading Private Placement Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased 14,000,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant, for an aggregate purchase price of $14,000,000. Each Private Placement Warrant is exercisable to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment. A portion of the proceeds from the Private Placement Warrants were added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds of the sale of the Private Placement Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law), and the Private Placement Warrants and all underlying securities will expire worthless. Promissory Notes — Related Parties On July 25, 2020, the Company issued an unsecured promissory note (the “2020 Promissory Note”) to the Sponsor, pursuant to which the Company could borrow up to an aggregate principal amount of $300,000. The 2020 Promissory Note was non-interest . Borrowings under this Promissory Note are no longer available. On December 24, 2021, the Company issued an unsecured promissory note (the “2021 Promissory Note”) to the Sponsor, pursuant to which Company could borrow up to an aggregate principal amount of $750,000. The 2021 Promissory Note is non-interest outstanding under the 2022 Promissory Note. On February 17, 2022, theCompany issued an unsecured promissory note (the “2022 Promissory Note”) to the Sponsor, pursuant to which Company could borrow up to an aggregate principal amount of $750,000. The 2021 Promissory Note may be converted to private placement warrants at a conversion rate equal to per warrant. The 2021 Promissory Note is reported at cost in the condensed financial statements as the fair value adjustment associated with the conversion is deemed to be de minimus. Related Party Loans In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (the “Working Capital Loans”). If the Company completes a Business Combination, the Company may repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans may be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post-Business Combination entity at a price of $1.00 per warrant. The warrants would be identical to the Private Placement Warrants. As of March 31, 2022 and December 31, 2021, the Company had no borrowings under the Working Capital Loans.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
Commitments and Contingencies	Mar. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	NOTE 5 — COMMITMENTS AND CONTINGENCIES Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy are not determinable as of the date of these condensed financial statements. The specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these condensed financial statements. Registration and Shareholder Rights Pursuant to a registration and shareholder rights agreement entered into on October 6, 2020, the holders of the Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans) will be entitled to registration rights. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination. However, the registration and shareholder rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lockup period. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The underwriters are entitled to a deferred fee of $0.35 per Unit, or $21,000,000 in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. Forward Purchase Agreement In connection with the consummation of the Initial Public Offering, the Company entered into a forward purchase agreement (the “FPA”) with the Sponsor, pursuant to which the Sponsor committed to purchase from the Company up to 10,000,000 forward purchase units, each consisting of one Class A ordinary share (“forward purchase share”) and one-half The proceeds from the sale of these forward purchase units, together with the amounts available to the Company from the Trust Account (after giving effect to any redemptions of Public Shares and the payment of deferred underwriting commissions) and any other equity or debt financing obtained by the Company in connection with a Business Combination, will be used to satisfy the cash requirements of the Business Combination, including funding the purchase price and paying expenses and retaining specified amounts to be used by the post-business combination company for working capital or other purposes. To the extent that the amounts available from the Trust Account and other financing are sufficient for such cash requirements, the Sponsor may purchase less than 10,000,000 forward purchase units. In addition, the Sponsor’s commitment under the FPA are subject to approval, prior to the Company entering into a definitive agreement for a Business Combination, of its investment committee.

Shareholder's Deficit

Shareholder's Deficit	3 Months Ended
Shareholder's Deficit	Mar. 31, 2022
Stockholders' Equity Note [Abstract]
Shareholder's Deficit	NOTE 6 — SHAREHOLDERS’ DEFICIT Preference Shares Class A Ordinary Shares Class B Ordinary Shares Holders of Class A ordinary shares and Class B ordinary shares will vote together as a single class on all other matters submitted to a vote of shareholders, except as required by law. The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of the Business Combination or earlier at the option of the holders thereof on a one-for-one as-converted

Warrants

Warrants	3 Months Ended
Warrants	Mar. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Warrants	NOTE 7 — WARRANTS As of March 31, 2022 and December 31, 2021 there were 30,000,000 Public Warrants outstanding. Public Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination and (b) 12 months from the closing of the Initial Public Offering. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. The Company will not be obligated to deliver any Class A ordinary shares pursuant to the exercise of a Public Warrant and will have no obligation to settle such Public Warrant exercise unless a registration statement under the Securities Act with respect to the Class A ordinary shares underlying the Public Warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations described below with respect to registration, or a valid exemption from registration is available. No Public Warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue a Class A ordinary share upon exercise of a Public Warrant unless the Class A ordinary share issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. The Company has agreed that as soon as practicable, but in no event later than twenty business days after the closing of the Company’s initial Business Combination, the Company will use its commercially reasonable efforts to file with the SEC a registration statement covering the Class A ordinary shares issuable upon exercise of the Public Warrants, and the Company will use its commercially reasonable efforts to cause the same to become effective within 60 business days after the closing of the Company’s initial Business Combination, and to maintain the effectiveness of such registration statement and a current prospectus relating to those Class A ordinary shares until the Public Warrants expire or are redeemed, as specified in the warrant agreement; provided that if the Company’s Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the 60th day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption, but the Company will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. Redemption of Warrants when the price per Class A ordinary share equals or exceeds $18.00. • in whole and not in part; • at a price of $0.01 per warrant; • upon a minimum of 30 days’ prior written notice of redemption; and • if, and only if, the reported closing price of the Company’s Class A ordinary shares equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30-trading The Company will not redeem the warrants as described above unless a registration statement under the Securities Act covering the issuance of the Class A ordinary shares issuable upon exercise of the warrants is then effective and a current prospectus relating to those Class A ordinary shares is available throughout the 30-day Once the warrants become exercisable, the Company may redeem the outstanding Public Warrants: • in whole and not in part; • at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption; provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares based on the redemption date and the “fair market value” of the Company’s Class A ordinary shares; • if, and only if, the last reported sale price (the “closing price”) of the Company’s Class A ordinary shares equals or exceeds $10.00 per Public Share (as adjusted) for any 20 trading days within the 30-trading • if the closing price of the Class A ordinary shares for any 20 trading days within a 30-trading If and when the Public Warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws. The exercise price and number of ordinary shares issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a share dividend, or recapitalization, reorganization, merger or consolidation. However, except as described below, the Public Warrants will not be adjusted for issuance of ordinary shares at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company has not completed a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their Public Warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination (excluding any forward purchase securities) at an issue price or effective issue price of less than $9.20 per ordinary share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Class A ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates a Business Combination (such price, the “Market Value”) is below $9.20 per share, then the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price. As of March 31, 2022 and December 31, 2021 there were 14,000,000 Private Placement Warrants outstanding. The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the Class A ordinary shares issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable on a cashless basis and be non-redeemable

Fair Value Measurements

Fair Value Measurements	3 Months Ended
Fair Value Measurements	Mar. 31, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements	NOTE 8 — FAIR VALUE MEASUREMENTS At March 31, 2022 and December 31, 2021, assets held in the Trust Account were comprised of $600,096,322 and $600,046,438 in money market funds which are invested in U.S. Treasury Securities, respectively. During the period ended March 31, 2022 and December 31, 2021, the Company did not withdraw any interest income from the Trust Account. The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at March 31, 2022 and December 31, 2021 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description Level March 31, 2022 December 31, 2021 Assets: Investments held in Trust Account 1 $ 600,096,322 $ 600,046,438 Liabilities: Warrant Liabilities — Public Warrants 1 $ 7,800,000 $ 17,760,000 Warrant Liabilities — Private Placement Warrants 2 $ 3,640,000 $ 8,288,000 FPA Liability 3 $ 29,991 $ 1,014,997 The Warrants and FPA liabilities were accounted for as liabilities in accordance with ASC815-40. The Warrants were initially valued using a Monte Carlo simulation, which is considered to be a Level 3 fair value measurement. The primary unobservable inputs utilized in determining the fair value of the Warrants the expected volatility of the ordinary shares. The expected volatility as of the Initial Public Offering date was derived from observable public warrant pricing on comparable ‘blank-check’ companies without an identified target. The subsequent measurements of the Public Warrants after the detachment of the Public Warrants from the Units are classified as Level 1 due to the use of an observable market quote in an active market. For periods subsequent to the detachment of the Public Warrants from the Units, the close price of the Public Warrant price was used as the fair value of the Warrants as of each relevant date. As the transfer of Private Placement Warrants to anyone outside of a small group of individuals who are permitted transferees would result in the Private Placement Warrants having substantially the same terms as the Public Warrants, the Company determined that the fair value of each Private Placement Warrant is equivalent to that of each Public Warrant. As such, the Private Placement Warrants are classified as Level 2. The liabilities for the FPA was valued using an adjusted net assets method, which is considered to be a Level 3 fair value measurement. Under the adjusted net assets method utilized, the aggregate commitment of $100 million pursuant to the FPA is discounted to present value and compared to the fair value of the ordinary shares and warrants to be issued pursuant to the FPA. The fair value of the ordinary shares and warrants to be issued under the FPA is based on the public trading price of the Units issued in the Company’s Initial Public Offering. The following table presents the quantitative information regarding Level 3 fair value measurements of the FPA liabilities: March 31, 2022 December 31, Risk-free interest rate 0.06 % 0.06 % Time to expiration, in Years 0.25 0.25 Unit price $ 10.10 $ 10.10 Forward Price $ 10.00 $ 10.00 The following table presents the changes in the fair value of FPA liabilities: FPA Fair value as of January 1, 2021 $ 8,483,278 Change in fair value (5,054,119 ) Fair value as of March 31, 2021 3,429,159 Fair value as of January 1, 2022 1,014,997 Change in fair value (985,006 ) Fair value as of March 31, 2022 29,991 Transfers to/from Levels 1, 2 and 3 are recognized at the end of the reporting period in which a change in valuation technique or methodology occurs. There were no transfers in or out of Level 3 from other levels in the fair value hierarchy during the year ended December 31, 2021. There were no transfer during the three months ended March 31, 2022 and during the year ended December 31, 2021.

Subsequent Events

Subsequent Events	3 Months Ended
Subsequent Events	Mar. 31, 2022
Subsequent Events [Abstract]
Subsequent Events	NOTE 9 — SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the condensed financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed financial statements.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies - (Policies)	3 Months Ended
Summary of Significant Accounting Policies - (Policies)	Mar. 31, 2022
Accounting Policies [Abstract]
Basis Of Presentation	Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q S-X The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K,
Emerging Growth Company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging
Use of Estimates	Use of Estimates The preparation of condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these condensed financial statements is the determination of the fair value of the warrant liability and FPA liability. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of March 31, 2022 and December 31, 2021.
Warrant and FPA Liabilities	Warrant and FPA Liabilities The Company accounts for the Warrants and FPA in accordance with the guidance contained in FASB Accounting Standards Codification (“ASC”) 815-40,
Class A Ordinary Shares Subject to Possible Redemption	Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in FASB ASC Topic 480 “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at March 31, 2022 and December 31, 2021, Class A ordinary shares subject to possible redemption are presented as temporary deficit, outside of the shareholders’ equity section of the Company’s condensed balance sheets. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares to equal the redemption value at the end of each reporting period. At March 31, 2022 and December 31, 2021, the Class A ordinary shares reflected in the condensed balance sheets are reconciled in the following table: Gross proceeds $ 600,000,000 Less: Proceeds allocated to Public Warrants (37,500,000 ) Class A ordinary shares issuance costs (31,473,651 ) Plus: Accretion of carrying value to redemption value 68,973,651 Class A ordinary shares subject to possible redemption $ 600,000,000
Offering Costs Associated with the Initial Public Offering	Offering Costs Associated with the Initial Public Offering Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. The Company classifies deferred underwriting commissions as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.
Income Tax	Income Taxes ASC Topic 740, “Income Taxes,” prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of March 31, 2022 and December 31, 2021, there were unrecognized tax benefits and amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the periods presented.
Net Income per Ordinary Share	Net Income per Ordinary Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income per ordinary share is computed by dividing net income by the weighted average number of ordinary shares outstanding for the period. The Company applies the two-class The calculation of diluted income per ordinary share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence of future events. The warrants are exercisable to purchase 44,000,000 Class A ordinary shares in the aggregate. For the three months ended March 31, 2022 and 2021, the Company did not have any other dilutive securities or other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted net income per ordinary shares is the same as basic net income per ordinary share for the periods presented. The following table reflects the calculation of basic and diluted net income per ordinary share (in dollars, except per share amounts): For the Three Months Ended For the Three Months Ended Class A Class B Class A Class B Basic and diluted net income per ordinary share Numerator: Allocation of net income, as adjusted $ 12,201,604 $ 3,050,401 $ 19,921,757 $ 4.980.43 Denominator: Basic and diluted weighted average shares outstanding 60,000,000 15,000,000 60,000,000 15,000,000 Basic and diluted net income per ordinary share $ 0.20 $ 0.20 $ 0.33 $ 0.33 Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the Company’s condensed balance sheets, primarily due to their short-term nature, except for the Warrants and FPA liability (see Note 8).
Fair Value Measurement	Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: • Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
Recent Accounting Standards	Recent Accounting Standards In August 2020, the FASB issued ASU 2020-06, (Subtopic 470-20) and (Subtopic 815-40) (“ASU 2020-06”) to ASU 2020-06 eliminates ASU 2020-06 amends the if-converted method ASU 2020-06 is ASU 2020-06 would Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed financial statements.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Table)	3 Months Ended
Summary of Significant Accounting Policies (Table)	Mar. 31, 2022
Earnings Per Share [Abstract]
Schedule of Class A ordinary shares reflected in the condensed balance sheets are reconciled in the following	At March 31, 2022 and December 31, 2021, the Class A ordinary shares reflected in the condensed balance sheets are reconciled in the following table: Gross proceeds $ 600,000,000 Less: Proceeds allocated to Public Warrants (37,500,000 ) Class A ordinary shares issuance costs (31,473,651 ) Plus: Accretion of carrying value to redemption value 68,973,651 Class A ordinary shares subject to possible redemption $ 600,000,000
Schedule of basic and diluted net loss per ordinary share	The following table reflects the calculation of basic and diluted net income per ordinary share (in dollars, except per share amounts): For the Three Months Ended For the Three Months Ended Class A Class B Class A Class B Basic and diluted net income per ordinary share Numerator: Allocation of net income, as adjusted $ 12,201,604 $ 3,050,401 $ 19,921,757 $ 4.980.43 Denominator: Basic and diluted weighted average shares outstanding 60,000,000 15,000,000 60,000,000 15,000,000 Basic and diluted net income per ordinary share $ 0.20 $ 0.20 $ 0.33 $ 0.33

Fair Value Measurements (Table)

Fair Value Measurements (Table)	3 Months Ended
Fair Value Measurements (Table)	Mar. 31, 2022
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Summary of assets and liabilities measured on a recurring basis	The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at March 31, 2022 and December 31, 2021 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description Level March 31, 2022 December 31, 2021 Assets: Investments held in Trust Account 1 $ 600,096,322 $ 600,046,438 Liabilities: Warrant Liabilities — Public Warrants 1 $ 7,800,000 $ 17,760,000 Warrant Liabilities — Private Placement Warrants 2 $ 3,640,000 $ 8,288,000 FPA Liability 3 $ 29,991 $ 1,014,997
Summary of quantitative information regarding Level 3 fair value measurements of warrants	The following table presents the quantitative information regarding Level 3 fair value measurements of the FPA liabilities: March 31, 2022 December 31, Risk-free interest rate 0.06 % 0.06 % Time to expiration, in Years 0.25 0.25 Unit price $ 10.10 $ 10.10 Forward Price $ 10.00 $ 10.00
Summary of changes in fair value of liabilities	The following table presents the changes in the fair value of FPA liabilities: FPA Fair value as of January 1, 2021 $ 8,483,278 Change in fair value (5,054,119 ) Fair value as of March 31, 2021 3,429,159 Fair value as of January 1, 2022 1,014,997 Change in fair value (985,006 ) Fair value as of March 31, 2022 29,991

Description of Organization a_2

Description of Organization and Business Operations - Additional Information (Detail) - USD ($)	Oct. 06, 2020	Mar. 31, 2022	Dec. 31, 2021
Description of Organization and Business Operations [Line Items]
Transaction costs	$ 33,588,903
Underwriting fees	12,000,000
Deferred underwriting fees	21,000,000
Other offering costs	$ 588,903
Percent of net assets held in the Trust Account for business combination	80.00%
Percent of outstanding voting right	50.00%
Minimum tangible assets required for business combination	$ 5,000,001
Percent of shares restricted for redemption	15.00%
Percent of redemption of public shares	100.00%
Interest on dissolution expenses	$ 100,000
Cash		$ 194,134	$ 67,132
Working Capital		843,236
Long-term Debt, Gross			$ 468,236
Founder Shares Member
Description of Organization and Business Operations [Line Items]
Payments of Stock Issuance Costs		25,000
Working Capital Loans Member
Description of Organization and Business Operations [Line Items]
Working Capital		519,612
Convertible Debt Current		1,500,000
Promissory Note Member [Member]
Description of Organization and Business Operations [Line Items]
Long-term Debt, Gross		300,000
Trust Account
Description of Organization and Business Operations [Line Items]
Share price	$ 10
Trust Account \| Maximum [Member]
Description of Organization and Business Operations [Line Items]
Share price	$ 10
Private Placement Warrants [Member]
Description of Organization and Business Operations [Line Items]
Number of warrants issued	14,000,000
Warrant issue price	$ 1
Proceeds from issuance of warrants	$ 14,000,000	$ 14,000,000
IPO
Description of Organization and Business Operations [Line Items]
Sale of stock, number of shares issued in transaction	60,000,000
Proceeds from issuance initial public offering	$ 600,000,000
Sale of stock, price per share	$ 10
Pro Rata
Description of Organization and Business Operations [Line Items]
Sale of stock, price per share	$ 10

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Unrecognized tax benefits	$ 0	$ 0
Unrecognized tax benefits, income tax penalties and interest accrued	$ 0	$ 0
Antidilutive securities	44,000,000
Federal depository insurance coverage	$ 250,000

Summary Of Significant Accoun_5

Summary Of Significant Accounting Policies - Schedule of Class A ordinary shares reflected in the condensed balance sheets are reconciled in the following (Detail) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Temporary Equity [Line Items]
Proceeds allocated to Public Warrants	$ (14,608,000)	$ (20,240,000)
Common Class A [Member]
Temporary Equity [Line Items]
Gross proceeds	600,000,000
Class A ordinary shares issuance costs	(31,473,651)
Accretion of carrying value to redemption value	68,973,651
Class A ordinary shares subject to possible redemption	600,000,000
Common Class A [Member] \| Common Stock [Member]
Temporary Equity [Line Items]
Proceeds allocated to Public Warrants	$ (37,500,000)

Summary of Significant Accoun_6

Summary of Significant Accounting Policies - Summary of basic and diluted net loss per ordinary share (Detail) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Numerator:
Allocation of net income	$ 15,252,005	$ 24,902,196
Class A Ordinary Share [Member]
Numerator:
Allocation of net income	$ 12,201,604	$ 19,921,757
Denominator:
Basic and diluted weighted average shares outstanding	60,000,000	60,000,000
Basic and diluted net income (loss) per ordinary share	$ 0.20	$ 0.33
Class B Ordinary Share [Member]
Numerator:
Allocation of net income	$ 3,050,401	$ 4,980,439
Denominator:
Basic and diluted weighted average shares outstanding	15,000,000	15,000,000
Basic and diluted net income (loss) per ordinary share	$ 0.20	$ 0.33

Initial Public Offering - Addit

Initial Public Offering - Additional Information (Detail)	Oct. 06, 2020$ / sharesshares
IPO
Sale of stock, number of shares issued in transaction \| shares	60,000,000
Sale of stock, price per share	$ 10
Warrant [Member]
Sale of stock, price per share	$ 11.50

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Detail) - USD ($)	Nov. 20, 2020	Oct. 06, 2020	Jul. 25, 2020	Mar. 31, 2022	Feb. 17, 2022	Dec. 31, 2021	Dec. 24, 2021	Oct. 16, 2020	Oct. 01, 2020	Sep. 30, 2020
Long-term Debt, Gross						$ 468,236
Sponsor [Member]
Notes Payable, Related Parties				$ 843,236
Promissory Note [Member]
Line of Credit Facility, Maximum Borrowing Capacity			$ 300,000		$ 750,000		$ 750,000
Long-term Debt, Gross								$ 300,000
Debt instrument, convertible, conversion price				$ 1.50
Working Capital Loans [Member]
Warrant issue price				$ 1
Convertible Debt				$ 1,500,000
Private Placement Warrants [Member]
Number of warrants issued				14,000,000
Warrant issue price				$ 1
Proceeds from issuance of warrants		$ 14,000,000		$ 14,000,000
Warrant exercise price				$ 11.50
Working Capital				$ 0		$ 0
Class B Ordinary Share [Member]
Common Stock, Par or Stated Value Per Share				$ 0.0001		$ 0.0001
Common Stock, Shares, Issued				15,000,000		15,000,000
Common Stock, Shares, Outstanding				15,000,000		15,000,000
Founder Shares [Member]
Payments of Stock Issuance Costs			25,000
Common Stock, Shares, Issued				15,000,000		15,000,000
Stock issued during period subject to forfeiture				2,250,000
Percent of stock convertible										20.00%
Stock price threshold limit				$ 12
Forfeiture of founder shares	2,250,000
Founder Shares [Member] \| Class B Ordinary Share [Member]
Proceeds from Issuance of Common Stock			$ 14,375,000
Common Stock, Par or Stated Value Per Share			$ 0.0001
Common Stock, Shares, Issued									17,250,000
Common Stock, Shares, Outstanding									17,250,000

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Detail)	3 Months Ended
	Mar. 31, 2022USD ($)$ / sharesshares
Deferred fee per unit \| $ / shares	$ 0.35
Deferred fee amount \| $	$ 21,000,000
Forward Purchase Units [Member]
Sale of stock, number of shares issued in transaction \| shares	10,000,000
Forward Purchase Units [Member] \| Maximum [Member]
Sale of stock, number of shares issued in transaction \| shares	10,000,000
Private Placement [Member]
Sale of stock, price per share \| $ / shares	$ 10
Sale of Stock, Consideration Received on Transaction \| $	$ 100,000,000

Shareholder's Deficit - Additio

Shareholder's Deficit - Additional Information (Details) - $ / shares	3 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Preferred Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Preferred Stock, Shares Authorized	5,000,000	5,000,000
Preferred Stock, Shares Issued	0	0
Preferred Stock, Shares Outstanding	0	0
Class A Ordinary Share [Member]
Common Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Common Stock, Shares Authorized	500,000,000	500,000,000
Common Stock, Shares, Issued	0	0
Common Stock, Shares, Outstanding	0	0
Common Stock Voting Rights	one vote for each share
Shares subject to possible redemption	60,000,000	60,000,000
Class B Ordinary Share [Member]
Common Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Common Stock, Shares Authorized	50,000,000	50,000,000
Common Stock, Shares, Issued	15,000,000	15,000,000
Common Stock, Shares, Outstanding	15,000,000	15,000,000
Common Stock Voting Rights	one vote for each share

Warrants - Additional Informati

Warrants - Additional Information (Detail)	3 Months Ended
Warrants - Additional Information (Detail)	Mar. 31, 2022$ / sharesshares	Mar. 31, 2022$ / sharesshares	Mar. 31, 2022Day$ / sharesshares	Mar. 31, 2022trading_days$ / sharesshares	Mar. 31, 2022$ / sharesshares	Dec. 31, 2021shares
Warrants [Line Items]
Percentage Of Proceeds From Share Issuances					60.00%
Minimum [Member]
Warrants [Line Items]
Warrants Redeemable, Threshold Consecutive Trading Days \| trading_days				20
Business Combination [Member] \| Class A Ordinary Share [Member]
Warrants [Line Items]
Business Acquisition, Share Price	$ 9.20	$ 9.20	$ 9.20	$ 9.20	$ 9.20
Public Warrants [Member]
Warrants [Line Items]
Minimum Lock In Period Required For Warrant Exercise From The Date Of Business Combination	30 days
Minimum Lock In Period Required For Warrant Exercise From The Date Of IPO	12 months
Minimum Period Required For Filing SEC Registration Statement From The Date Of Business Combination	60 days
Class of warrants or rights outstanding \| shares	30,000,000	30,000,000	30,000,000	30,000,000	30,000,000	30,000,000
Public Warrants [Member] \| Minimum [Member]
Warrants [Line Items]
Warrants Exercise Price Adjustment Percentage					115.00%
Public Warrants [Member] \| Share Trigger Price One [Member]
Warrants [Line Items]
Minimum Share Price Required For Redemption Of Warrants		$ 10
Warrants, Redemption Price Per Share	$ 0.01	0.01	$ 0.01	$ 0.01	$ 0.01
Warrants Redeemable, Threshold Consecutive Trading Days \| Day			20
Warrants Redeemable, Threshold Trading Days			30	30
Minimum Notice Period For Warrants Redemption	30 days
Public Warrants [Member] \| Share Trigger Price One [Member] \| Maximum [Member]
Warrants [Line Items]
Warrants Exercise Price Adjustment Percentage					180.00%
Public Warrants [Member] \| Share Trigger Price Two [Member]
Warrants [Line Items]
Minimum Share Price Required For Redemption Of Warrants		10
Warrants, Redemption Price Per Share	$ 0.10	0.10	$ 0.10	$ 0.10	$ 0.10
Warrants Redeemable, Threshold Consecutive Trading Days \| Day			20
Warrants Redeemable, Threshold Trading Days \| Day			30
Public Warrants [Member] \| Class A Ordinary Share [Member] \| Share Trigger Price One [Member]
Warrants [Line Items]
Minimum Share Price Required For Redemption Of Warrants		18
Public Warrants [Member] \| Class A Ordinary Share [Member] \| Share Trigger Price Two [Member]
Warrants [Line Items]
Minimum Share Price Required For Redemption Of Warrants		$ 10
Private Placement Warrants [Member]
Warrants [Line Items]
Class of warrants or rights outstanding \| shares	14,000,000	14,000,000	14,000,000	14,000,000	14,000,000
Private Placement Warrants [Member] \| Class A Ordinary Share [Member]
Warrants [Line Items]
Minimum Share Price Required For Redemption Of Warrants		$ 10

Fair Value Measurements - Addit

Fair Value Measurements - Additional information (Detail) - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities held in Trust Account	$ 600,096,322	$ 600,046,438
Forward Purchase Agreement Liability [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Financial liabilities commitement	100,000,000
Money Market Funds [Member] \| US Treasury Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities held in Trust Account	$ 600,096,322	$ 600,046,438

Fair Value Measurements - Summa

Fair Value Measurements - Summary of assets and liabilities measured on a recurring basis (Detail) - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Assets [Abstract]
Marketable securities held in Trust Account – U.S. Treasury Securities Money Market Fund	$ 600,096,322	$ 600,046,438
Fair Value, Recurring [Member] \| Level 1 [Member]
Assets [Abstract]
Marketable securities held in Trust Account – U.S. Treasury Securities Money Market Fund	600,096,322	600,046,438
Fair Value, Recurring [Member] \| Level 1 [Member] \| Derivative Financial Instruments, Liabilities [Member] \| Warrant [Member] \| Public Warrants [Member]
Liabilities [Abstract]
Financial Liabilities Fair Value Disclosure	7,800,000	17,760,000
Fair Value, Recurring [Member] \| Level 2 [Member] \| Derivative Financial Instruments, Liabilities [Member] \| Warrant [Member] \| Private Placement Warrants [Member]
Liabilities [Abstract]
Financial Liabilities Fair Value Disclosure	3,640,000	8,288,000
Fair Value, Recurring [Member] \| Level 3 [Member] \| FPA Liability
Liabilities [Abstract]
Financial Liabilities Fair Value Disclosure	$ 29,991	$ 1,014,997

Fair Value Measurements - Sum_2

Fair Value Measurements - Summary of Quantitative Information Regarding Level 3 Fair Value Measurements of Warrants (Detail) - Level 3 [Member] - Forward Purchase Agreement Liability [Member] - $ / shares	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Risk-free interest rate	0.06%	0.06%
Time to expiration, in Years	3 months	3 months
Unit price	$ 10.10	$ 10.10
Forward Price	$ 10	$ 10

Fair Value Measurements - Sum_3

Fair Value Measurements - Summary of Changes In Fair Value of Liabilities (Detail) - Warrant [Member] - Private Placement Warrants [Member] - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair value, Beginning balance	$ 1,014,997	$ 8,483,278
Change in fair value	(985,006)	(5,054,119)
Fair value, Ending balance	$ 29,991	$ 3,429,159